First Death Attributed to AstraZeneca Reported in Alberta, Canada

A woman in her 50’s from Alberta, Canada has died from a blood clot after receiving the AstraZeneca COVID-19 vaccine.

The woman, identified as 52-year-old Lisa Stonehouse, died after being transferred to the University of Alberta Hospital.

Dr. Deena Hinshaw, Alberta’s chief medical officer of health, confirmed Tuesday that a woman in her 50s died of vaccine-induced immune thrombotic thrombocytopenia (VITT) after receiving the AstraZeneca vaccine but did not specify if it was Stonehouse. 

“The Alberta case marks the second VITT case and only death related to  VITT out of more than 253,000 doses of AstraZeneca or  CoviSHIELD/AstraZeneca that have been administered in Alberta to date,” explained Hinshaw.

Hinshaw clarified that there has only been one case of VTT in 100,000 to 250,000 doses of the AstraZeneca vaccine globally. 

According to Stonehouse’s family friend Wilfred Lowenberg, Lisa was vaccinated with AstraZeneca on April 21 and developed an adverse reaction later on.

On April 29, Stonehouse’s symptoms worsened, and she was advised by Canada’s Health Link that she was likely suffering from a normal vaccine reaction,

Stonehouse’s daughter later drove her to the ER at the Grey Nuns Community Hospital in southeast Edmonton but was turned away.

A CT scan at the Strathcona Community Hospital showed a blood clot had formed in Stonehouse’s head.

Stonehouse was then transferred to the University of Alberta Hospital where she was intubated.

© Fourth Estate® — All Rights Reserved.
This material may not be published, broadcast, rewritten or redistributed.